| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.8 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.8 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.9 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.9 |